Can stem cells heal the brain after a stroke? new trial aims to find out

NCT ID NCT05008588

Ongoing Disease control Sponsor: PT. Prodia Stem Cell Indonesia Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-phase trial tests a combination of umbilical cord stem cells (injected into the brain) and a liquid called conditioned medium (given as nose drops) in 15 people who recently had a stroke. The goal is to see if this approach is safe and can help the brain grow new cells. Researchers will measure changes in blood markers and brain scans over six months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: umbilical cord stem cells and conditioned medium (secretome)
What this could lead to: If it works, this could point toward a new way to help the brain repair itself after a stroke, possibly improving recovery.
What could go wrong: This is a very early, small trial (15 people) with no placebo group. The treatment involves brain injections, which carry risks like bleeding or infection. Success is far from guaranteed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ischemic stroke

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ISCHEMIC STROKE

Contacts and locations

Locations

Gatot Soebroto Hospital

Jakarta Pusat, DKI Jakarta, 10410, Indonesia
PT Prodia StemCell Indonesia

Jakarta, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.